Statistics
Publications
2
Citations
188
H-Index
2
Active since
2014
Affiliations
Yi-Xiang Zhang is an author at Dana-Farber Cancer Institute specializing in molecular oncology, cancer pharmacology, and cancer cell proliferation inhibition.
Publications per year
2014–2016
2
2
Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
Robert Nakayama, Yi-Xiang Zhang, Jeffrey T. Czaplinski et al. · Oncotarget · 2016 · 75 citations · Full text
Medicine, Oncology, Pharmacology +16
1–2 of 2